Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...
Limited (HK:0013) has released an update. HUTCHMED (China) Limited is set to showcase new clinical data at the 2024 ASH Annual ...
Panic surrounding dengue or chikungunya and many new testing centres having come up in the state capital - diaognosing more people - are termed as the reasons for the spike ...
HONG KONG, SHANGHAI, and FLORHAM PARK, N.J., Nov. 05, 2024 (GLOBE NEWSWIRE) -- (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from the sovleplenib ESLIM-01 Phase III ...
In a world where medical advancements often steal the spotlight, one act of kindness continues to save lives in profound ways ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback